PRTC — Puretech Health Income Statement
0.000.00%
Last trade - 00:00- £301.68m
- -£64.62m
- $3.33m
Annual income statement for Puretech Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 9.81 | 11.8 | 17.4 | 15.6 | 3.33 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | -522 | 131 | 168 | 166 | 87.7 |
| Operating Profit | 532 | -120 | -150 | -151 | -84.4 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 478 | 19 | -59 | -92.8 | -36.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 366 | 4.57 | -62.7 | -37.1 | -66.6 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 421 | 5.99 | -60.6 | -50.4 | -65.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 421 | 5.99 | -60.6 | -50.4 | -65.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.044 | 0.021 | -0.211 | -0.281 | -0.38 |